| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | JPMORGAN CHASE & CO | 3,410,000 | 112,837,000 | 34.82% | ||
| 2 | ISHARES TR | 1,895,400 | 108,645,000 | 33.52% | ||
| 3 | ESCALON MEDICAL CORP NEW | 2,703,700 | 95,900,000 | 29.59% | ||
| 4 | INTRICON CORP | 33,927 | 5,835,000 | 1.80% | ||
| 5 | Atara Biotherapeutics Inc | 9,260 | 291,000 | 0.09% | ||
| 6 | IRONWOOD PHARMACEUTICALS INC COM CL A | 6,238 | 250,000 | 0.08% | ||
| 7 | ISHARES TR | 4,000 | 244,000 | 0.08% | ||
| 8 | CORCEPT THERAPEUTICS INC | 22,334 | 84,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000938582-15-000007, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
